AQR Capital Management LLC Decreases Stock Holdings in Axon Enterprise, Inc $AXON

AQR Capital Management LLC lowered its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 16.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,496 shares of the biotechnology company’s stock after selling 3,867 shares during the period. AQR Capital Management LLC’s holdings in Axon Enterprise were worth $9,986,000 at the end of the most recent quarter.

Several other large investors have also recently bought and sold shares of AXON. TCTC Holdings LLC lifted its holdings in Axon Enterprise by 75.0% during the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock worth $29,000 after buying an additional 24 shares during the last quarter. Fourth Dimension Wealth LLC acquired a new stake in shares of Axon Enterprise during the 4th quarter worth about $30,000. Bartlett & CO. Wealth Management LLC lifted its stake in Axon Enterprise by 132.0% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company’s stock worth $31,000 after purchasing an additional 33 shares during the last quarter. Catalyst Capital Advisors LLC purchased a new stake in Axon Enterprise during the first quarter worth approximately $32,000. Finally, Alpine Bank Wealth Management acquired a new position in Axon Enterprise in the first quarter valued at approximately $40,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Trading Up 2.1%

NASDAQ:AXON opened at $747.55 on Thursday. Axon Enterprise, Inc has a 12-month low of $353.91 and a 12-month high of $885.91. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. The stock’s 50 day simple moving average is $762.78 and its 200-day simple moving average is $682.93. The firm has a market cap of $58.68 billion, a P/E ratio of 184.58, a PEG ratio of 26.87 and a beta of 1.40.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.58. The firm had revenue of $668.54 million for the quarter, compared to analyst estimates of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. Axon Enterprise’s quarterly revenue was up 32.6% on a year-over-year basis. During the same period last year, the firm posted $1.20 EPS. Axon Enterprise has set its FY 2025 guidance at EPS. Equities analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on AXON. Northland Securities set a $800.00 price objective on shares of Axon Enterprise in a report on Tuesday, August 5th. Needham & Company LLC set a $870.00 target price on shares of Axon Enterprise and gave the company a “buy” rating in a research report on Tuesday, August 5th. Craig Hallum raised shares of Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 price target for the company in a research report on Tuesday, August 5th. Morgan Stanley set a $885.00 price objective on shares of Axon Enterprise and gave the company an “overweight” rating in a research note on Friday, July 11th. Finally, Raymond James Financial reiterated an “outperform” rating and set a $855.00 target price (up previously from $645.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. Thirteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average target price of $837.69.

Insider Buying and Selling

In other news, Director Hadi Partovi acquired 1,358 shares of Axon Enterprise stock in a transaction that occurred on Wednesday, August 13th. The stock was purchased at an average price of $740.00 per share, for a total transaction of $1,004,920.00. Following the completion of the transaction, the director directly owned 237,938 shares in the company, valued at approximately $176,074,120. This trade represents a 0.57% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jeffrey C. Kunins sold 7,891 shares of the business’s stock in a transaction that occurred on Thursday, August 14th. The stock was sold at an average price of $750.10, for a total value of $5,919,039.10. Following the transaction, the insider owned 144,538 shares in the company, valued at $108,417,953.80. The trade was a 5.18% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 44,865 shares of company stock worth $34,362,833. 4.40% of the stock is currently owned by insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.